Business Wire

PREVENA™ Therapy Becomes the First and Only Negative Pressure Medical Device FDA-Indicated to Aid in the Reduction of Superficial Surgical Site Infections (SSIs) in Patients ...

SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s De Novo request for the PREVENA™ Incision Management ...
Nasdaq

New Data from PROMISES Study Shows PREVENA™ Incision Management System Significantly Reduces Major Complications and Readmissions Compared to Standard of Care

Research presented at the 30th American Association of Hip and Knee Surgeons Annual Meeting (AAHKS) builds on existing evidence that PREVENA™ Therapy lowers surgical site complications and readmission ...
Orthopedics This Week

Smith+Nephew comparative study1 shows PICO sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare cost…

Smith+Nephew announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure ...
Business Wire

New Data from PROMISES Study Shows PREVENA™ Incision Management System Significantly Reduces Major Complications and Readmissions Compared to Standard of Care

ST. PAUL, Minn.--(BUSINESS WIRE)--3M today announced new data demonstrating the PREVENA™ Incision Management System significantly mitigated 90-day surgical site complications (SSCs) and readmission ...